Try it
Pharmacology · Neuro drugs: riluzole
Sample itemWhich drug that reduces glutamate release prolongs survival modestly in amyotrophic lateral sclerosis?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Riluzole
Riluzole inhibits presynaptic glutamate release and blocks sodium channels, and slightly prolongs survival in ALS. Liver enzymes should be monitored.
Option by option
A. Pramipexole
Pramipexole is a dopamine agonist.
B. Baclofen
Baclofen relieves spasticity.
C. Donepezil
Donepezil is a cholinesterase inhibitor for Alzheimer disease.
D. Riluzole (correct)
Correct. Riluzole is the glutamate-modulating agent used in ALS.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?